Katarina Fehir Šola
Katarina Fehir Šola has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Piotr Merks
Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, 01-938 Warsaw, Poland
6 shared publications - Urszula Religioni
CMKP, School of Public Health
4 shared publications - Agnieszka Neumann-Podczaska
Senior Institute, Department of Medical and Health Sciences, Vizja University, Warsaw, Poland
3 shared publications - Eliza Blicharska
Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Medical University of Lublin, 1 Chodzki St., 20-093 Lublin, Poland
3 shared publications - Justyna Kaźmierczak
Zdrowit sp. z o.o., Pharmacy Chain, 41-940 Piekary Śląskie, Poland
3 shared publications - Donatella Verbanac
Department of Medical Biochemistry and Hematology, University of Zagreb Faculty of Pharmacy and Biochemistry, 10000 Zagreb, Croatia
2 shared publications
Latest Publications
- Open Access
Evidence-Based Nutritional Assessment, Intervention, and Supplementation in the First 1000 Days: A Community Pharmacy Perspective
The first 1000 days, from conception to the second birthday, represent a period of exceptional developmental plasticity during which nutritional exposures may influence metabolic, immune, and neurodevelopmental trajectories. Nutritional assessment during this period requires distinction between universally recommended preventive interventions, targeted supplementation for defined risk groups, correction of documented deficiency, and avoidance of unnecessary or excessive nutrient intake. This narrative review synthesizes current evidence on nutritional assessment, intervention, and supplementation across preconception, pregnancy, lactation, infancy, and complementary feeding. Periconceptional folic acid remains the most consistently supported universal intervention, whereas recommendations for iron, multiple micronutrients, calcium, iodine, vitamin D, omega-3 fatty acids, and choline depend to varying degrees on maternal nutritional status, dietary intake, population context, and clinical risk, and they should be checked against upper intake levels to avoid excess. During lactation and infancy, nutritional care extends beyond supplementation to breastfeeding support, medication safety, infant micronutrient prophylaxis, and assessment of feeding difficulties. From approximately 6 months, complementary feeding requires attention to dietary diversity, nutrient adequacy, allergen introduction, and avoidance of unnecessary dietary restriction. Because several preventive interventions must begin before conception to influence pregnancy and infant outcomes, preconception nutrition is included within the developmental framework of this review. Community pharmacy is considered as an accessible point of care through which this evidence may be translated into practice. Accordingly, the review maps the nutritional evidence onto a stage-structured pharmaceutical care pathway and uses the Croatian Breastfeeding-Friendly Pharmacy initiative as an implementation example. The proposed framework illustrates how evidence-based nutritional assessment, supplementation, counselling, and referral may be operationalised in community practice but requires prospective evaluation before its effectiveness can be established.
Open AccessEvidence-Based Nutritional Assessment, Intervention, and Supplementation in the First 1000 Days: A Community Pharmacy Perspective
The first 1000 days, from conception to the second birthday, represent a period of exceptional developmental plasticity during which nutritional exposures may influence metabolic, immune, and neurodevelopmental trajectories. Nutritional assessment during this period requires distinction between universally recommended preventive interventions, targeted supplementation for defined risk groups, correction of documented deficiency, and avoidance of unnecessary or excessive nutrient intake. This narrative review synthesizes current evidence on nutritional assessment, intervention, and supplementation across preconception, pregnancy, lactation, infancy, and complementary feeding. Periconceptional folic acid remains the most consistently supported universal intervention, whereas recommendations for iron, multiple micronutrients, calcium, iodine, vitamin D, omega-3 fatty acids, and choline depend to varying degrees on maternal nutritional status, dietary intake, population context, and clinical risk, and they should be checked against upper intake levels to avoid excess. During lactation and infancy, nutritional care extends beyond supplementation to breastfeeding support, medication safety, infant micronutrient prophylaxis, and assessment of feeding difficulties. From approximately 6 months, complementary feeding requires attention to dietary diversity, nutrient adequacy, allergen introduction, and avoidance of unnecessary dietary restriction. Because several preventive interventions must begin before conception to influence pregnancy and infant outcomes, preconception nutrition is included within the developmental framework of this review. Community pharmacy is considered as an accessible point of care through which this evidence may be translated into practice. Accordingly, the review maps the nutritional evidence onto a stage-structured pharmaceutical care pathway and uses the Croatian Breastfeeding-Friendly Pharmacy initiative as an implementation example. The proposed framework illustrates how evidence-based nutritional assessment, supplementation, counselling, and referral may be operationalised in community practice but requires prospective evaluation before its effectiveness can be established.
- Open Access
Professional Fulfilment in Pharmacy: A Cross-Sectional Survey of Pharmacists in 17 European Countries
Background/Objectives: Pharmacists play an essential role in healthcare delivery across Europe, yet growing professional demands, organisational constraints, and evolving practice models may negatively affect job satisfaction and professional fulfilment. This study aimed to evaluate job satisfaction and professional perception among pharmacists across multiple European countries and to identify sociodemographic and workplace-related factors associated with these outcomes. Methods: A cross-sectional, web-based survey was conducted between October 2023 and January 2024 among licensed pharmacists from 17 European countries. Eligible participants were pharmacists employed in community pharmacies, hospitals, clinical pharmacy services, or the pharmaceutical industry. The questionnaire, developed and administered in English, collected sociodemographic and professional data and included two composite measures: the Job Satisfaction Scale (12 items) and the Pharmacist Professional Perception Scale (6 items). Responses were recorded using 5-point Likert scales. Descriptive statistics and inferential analyses were performed using SPSS version 27.0. Results: A total of 789 pharmacists participated (median age 40 years; 80.1% female). The mean job satisfaction score was 3.26 (SD 0.88), with the lowest scores related to staffing adequacy and salary, and the highest to collegial relationships. The mean professional perception score was 3.08 (SD 0.81), indicating moderate perceived professional recognition. Significant associations were identified between both scales and workplace setting, income level, employment status, geographical region, education, and professional experience (p < 0.05). Conclusions: In this multi-country convenience sample, pharmacists reported moderate levels of job satisfaction and professional perception, with variation across workplace and sociodemographic factors. These findings should be interpreted cautiously, as the sample is not representative of all European pharmacists; however, they suggest that staffing conditions, remuneration, professional recognition, and career development opportunities may be relevant areas for further investigation and policy attention.
Open AccessProfessional Fulfilment in Pharmacy: A Cross-Sectional Survey of Pharmacists in 17 European Countries
Background/Objectives: Pharmacists play an essential role in healthcare delivery across Europe, yet growing professional demands, organisational constraints, and evolving practice models may negatively affect job satisfaction and professional fulfilment. This study aimed to evaluate job satisfaction and professional perception among pharmacists across multiple European countries and to identify sociodemographic and workplace-related factors associated with these outcomes. Methods: A cross-sectional, web-based survey was conducted between October 2023 and January 2024 among licensed pharmacists from 17 European countries. Eligible participants were pharmacists employed in community pharmacies, hospitals, clinical pharmacy services, or the pharmaceutical industry. The questionnaire, developed and administered in English, collected sociodemographic and professional data and included two composite measures: the Job Satisfaction Scale (12 items) and the Pharmacist Professional Perception Scale (6 items). Responses were recorded using 5-point Likert scales. Descriptive statistics and inferential analyses were performed using SPSS version 27.0. Results: A total of 789 pharmacists participated (median age 40 years; 80.1% female). The mean job satisfaction score was 3.26 (SD 0.88), with the lowest scores related to staffing adequacy and salary, and the highest to collegial relationships. The mean professional perception score was 3.08 (SD 0.81), indicating moderate perceived professional recognition. Significant associations were identified between both scales and workplace setting, income level, employment status, geographical region, education, and professional experience (p < 0.05). Conclusions: In this multi-country convenience sample, pharmacists reported moderate levels of job satisfaction and professional perception, with variation across workplace and sociodemographic factors. These findings should be interpreted cautiously, as the sample is not representative of all European pharmacists; however, they suggest that staffing conditions, remuneration, professional recognition, and career development opportunities may be relevant areas for further investigation and policy attention.
- Open Access
- 10 July 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (2) , 1-10
Pharmacists’ Recommendations to Reduce Drug Therapy Problems in Nursing Home Residents
Objective: Comprehensive Medication Management Services (CMM) are clinical services based on pharmaceutical care, and represents a patient-centred approach in which the pharmacist takes the responsibility for the patient’s needs. This study aimed to describe drug therapy problems among nursing home residents, identified through pharmacists’ provision of CMM, and assess physicians’ acceptance of pharmacists’ recommendations. Methods: A cross-sectional observational study was conducted from February 2018 to January 2019 in a nursing home in Croatia. Utilizing the Pharmacotherapy Workup method by Cipolle et al., pharmacists assessed and classified DTPs related to indication, effectiveness, safety, and adherence. Recommendation included medication discontinuation, dose adjustments and patient education. Results: Sixty residents were included in the study. Median age was 79.9 (IQR 66.1 – 96.7) years. On average, residents used 7 (IQR 2–16) medications and had 5 (IQR 1–12) comorbidities. In total, 141 DTPs were identified (4.3 ± SD2.35 per resident). The most prevalent DTP was” additional drug therapy needed” (n =55; 39%), falling into the effectiveness category. The pharmacists suggested 133 modifications for the identified DTPs. Physicians accepted a total number of 112 recommendations (84.21%). Conclusion: The high prevalence of DTPs identified and substantial acceptance of pharmacists’ recommendations strongly suggests the need to incorporate CMM services within long-term care facilities with intent to improve quality of care. The results demonstrate that pharmacists are pivotal in optimizing therapeutic outcomes through effective medication management.
- 10 July 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (2) , 1-10
Open AccessPharmacists’ Recommendations to Reduce Drug Therapy Problems in Nursing Home Residents
Objective: Comprehensive Medication Management Services (CMM) are clinical services based on pharmaceutical care, and represents a patient-centred approach in which the pharmacist takes the responsibility for the patient’s needs. This study aimed to describe drug therapy problems among nursing home residents, identified through pharmacists’ provision of CMM, and assess physicians’ acceptance of pharmacists’ recommendations. Methods: A cross-sectional observational study was conducted from February 2018 to January 2019 in a nursing home in Croatia. Utilizing the Pharmacotherapy Workup method by Cipolle et al., pharmacists assessed and classified DTPs related to indication, effectiveness, safety, and adherence. Recommendation included medication discontinuation, dose adjustments and patient education. Results: Sixty residents were included in the study. Median age was 79.9 (IQR 66.1 – 96.7) years. On average, residents used 7 (IQR 2–16) medications and had 5 (IQR 1–12) comorbidities. In total, 141 DTPs were identified (4.3 ± SD2.35 per resident). The most prevalent DTP was” additional drug therapy needed” (n =55; 39%), falling into the effectiveness category. The pharmacists suggested 133 modifications for the identified DTPs. Physicians accepted a total number of 112 recommendations (84.21%). Conclusion: The high prevalence of DTPs identified and substantial acceptance of pharmacists’ recommendations strongly suggests the need to incorporate CMM services within long-term care facilities with intent to improve quality of care. The results demonstrate that pharmacists are pivotal in optimizing therapeutic outcomes through effective medication management.
- Open Access
- 21 March 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (7) , 693
Patient Satisfaction with Pharmacist-Led COVID-19 Testing in Community Pharmacies: Insights from the Croatian Experience
Background/Objective: Pharmacists are among the most accessible healthcare professionals, playing a crucial role in public health. In response to the ongoing COVID-19 pandemic, many countries, including Croatia, have expanded the responsibilities of pharmacists. Since November 2021, Croatian pharmacists have been authorized to provide COVID-19 testing in community pharmacies. This study explores patients’ perceptions of these pharmacy-based testing services. Methods: This study employed a quantitative research approach, utilizing a structured questionnaire as the primary data collection tool. The research was conducted between November 2021 and January 2022, with a total of 211 participants from diverse backgrounds. Results: The findings demonstrate a highly positive perception of COVID-19 testing services in community pharmacies. A significant majority (95.2%) of patients found pharmacist-administered testing to be convenient. Additionally, 92.3% believed that pharmacists possess the necessary skills to perform the tests, and 94.7% expressed willingness to undergo testing in a pharmacy again. Notably, 94% of respondents indicated their intention to utilize pharmacists’ services for future testing. Conclusions: Croatian patients exhibit a strong positive attitude towards pharmacist-led COVID-19 testing in community pharmacies. These findings highlight the pivotal role of pharmacists in enhancing healthcare accessibility and demonstrate the value of integrating pharmacy-based testing services into public health strategies. This study provides valuable insights into the evolving role of pharmacists in healthcare delivery.
- 21 March 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (7) , 693
Open AccessPatient Satisfaction with Pharmacist-Led COVID-19 Testing in Community Pharmacies: Insights from the Croatian Experience
Background/Objective: Pharmacists are among the most accessible healthcare professionals, playing a crucial role in public health. In response to the ongoing COVID-19 pandemic, many countries, including Croatia, have expanded the responsibilities of pharmacists. Since November 2021, Croatian pharmacists have been authorized to provide COVID-19 testing in community pharmacies. This study explores patients’ perceptions of these pharmacy-based testing services. Methods: This study employed a quantitative research approach, utilizing a structured questionnaire as the primary data collection tool. The research was conducted between November 2021 and January 2022, with a total of 211 participants from diverse backgrounds. Results: The findings demonstrate a highly positive perception of COVID-19 testing services in community pharmacies. A significant majority (95.2%) of patients found pharmacist-administered testing to be convenient. Additionally, 92.3% believed that pharmacists possess the necessary skills to perform the tests, and 94.7% expressed willingness to undergo testing in a pharmacy again. Notably, 94% of respondents indicated their intention to utilize pharmacists’ services for future testing. Conclusions: Croatian patients exhibit a strong positive attitude towards pharmacist-led COVID-19 testing in community pharmacies. These findings highlight the pivotal role of pharmacists in enhancing healthcare accessibility and demonstrate the value of integrating pharmacy-based testing services into public health strategies. This study provides valuable insights into the evolving role of pharmacists in healthcare delivery.
- Open Access
Development and Validation of a Tool to Explore Attitudes Towards meDication adHErence Using a Novel Self-Reported QuestionnairE (ADHERE-7)
Despite the availability of various tools for measuring medication adherence, efficiently identifying non-adherence levels and reasons at the point of care remains challenging. Existing tools often lack the ease of use needed for practical clinical application. This study aimed to develop and validate a user-friendly tool to provide healthcare professionals with a concise yet comprehensive means of identifying adherence behaviors. The methodology consisted of two phases: tool items were first developed using the nominal group technique with healthcare professionals, followed by a cross-sectional pilot study involving community-dwelling adults in Croatia. Validation analysis indicated acceptable face and content validity and satisfactory criterion validity, with Attitudes towards meDication adHErence self-Reported questionnairE (ADHERE-7) scores correlating with both the self-reported five-item Medication Adherence Report Scale (MARS-5 tool) (ρ = 0.765; p < 0.001) and an objective measure of the proportion of days covered (PDC) from pharmacy prescription claims data (G = 0.586; p = 0.015). Construct validity revealed three factors: Aversion, Comfort, and Practical Non-Adherence, with Cronbach’s alpha values of 0.617 for Aversion and 0.714 for Comfort Non-Adherence. The mean total score for ADHERE-7 was 26.27 ± 2.41 (range 17 to 28). This robust validation process confirms the ADHERE-7 tool as a reliable instrument for assessing medication adherence, addressing aversion, comfort, practical issues, and both intentional and unintentional nonadherence.
Open AccessDevelopment and Validation of a Tool to Explore Attitudes Towards meDication adHErence Using a Novel Self-Reported QuestionnairE (ADHERE-7)
Despite the availability of various tools for measuring medication adherence, efficiently identifying non-adherence levels and reasons at the point of care remains challenging. Existing tools often lack the ease of use needed for practical clinical application. This study aimed to develop and validate a user-friendly tool to provide healthcare professionals with a concise yet comprehensive means of identifying adherence behaviors. The methodology consisted of two phases: tool items were first developed using the nominal group technique with healthcare professionals, followed by a cross-sectional pilot study involving community-dwelling adults in Croatia. Validation analysis indicated acceptable face and content validity and satisfactory criterion validity, with Attitudes towards meDication adHErence self-Reported questionnairE (ADHERE-7) scores correlating with both the self-reported five-item Medication Adherence Report Scale (MARS-5 tool) (ρ = 0.765; p < 0.001) and an objective measure of the proportion of days covered (PDC) from pharmacy prescription claims data (G = 0.586; p = 0.015). Construct validity revealed three factors: Aversion, Comfort, and Practical Non-Adherence, with Cronbach’s alpha values of 0.617 for Aversion and 0.714 for Comfort Non-Adherence. The mean total score for ADHERE-7 was 26.27 ± 2.41 (range 17 to 28). This robust validation process confirms the ADHERE-7 tool as a reliable instrument for assessing medication adherence, addressing aversion, comfort, practical issues, and both intentional and unintentional nonadherence.
- Open Access
- 21 October 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (20) , 13642
Implementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland
Background: Non-adherence occurs in various groups of patients, including those with chronic diseases. One strategy to increase adherence among oncological patients is to individualise treatment and expand pharmaceutical care. Pharmaceutical labels that remind patients how they should take their medications are of great importance in this respect. Objective: The main objective of this study was to evaluate medication adherence in oncological patients, and to gather their opinions on the individual medication labelling system as an element of effective treatment. Methods: The study was conducted in 2021 among 82 patients of the oncological department of the Centre of Oncology in Radom. The research tool was a questionnaire consisting of personal data and two parts relating to the patient’s disease and the medication labelling system. Results: Nearly half of the respondents reported that they forget to take medications and how they should take them. These problems increased with the age of the patient and the number of administered medications. Of the respondents, 89% stated that the labels with dosing information are helpful. Over 67% agreed that these labels should be affixed to all medications. Nearly 90% of the respondents believed the labels should be available in all pharmacies. Conclusions: Non-adherence is a common phenomenon among oncological patients. Pharmacists providing a labelling service for medicinal products can play a significant role in reducing this phenomenon.
- 21 October 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (20) , 13642
Open AccessImplementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland
Background: Non-adherence occurs in various groups of patients, including those with chronic diseases. One strategy to increase adherence among oncological patients is to individualise treatment and expand pharmaceutical care. Pharmaceutical labels that remind patients how they should take their medications are of great importance in this respect. Objective: The main objective of this study was to evaluate medication adherence in oncological patients, and to gather their opinions on the individual medication labelling system as an element of effective treatment. Methods: The study was conducted in 2021 among 82 patients of the oncological department of the Centre of Oncology in Radom. The research tool was a questionnaire consisting of personal data and two parts relating to the patient’s disease and the medication labelling system. Results: Nearly half of the respondents reported that they forget to take medications and how they should take them. These problems increased with the age of the patient and the number of administered medications. Of the respondents, 89% stated that the labels with dosing information are helpful. Over 67% agreed that these labels should be affixed to all medications. Nearly 90% of the respondents believed the labels should be available in all pharmacies. Conclusions: Non-adherence is a common phenomenon among oncological patients. Pharmacists providing a labelling service for medicinal products can play a significant role in reducing this phenomenon.
- Open Access
- 4 August 2022
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 76 (12) , 1675-1681
The effect of multistrain probiotics on functional constipation in the elderly: a randomized controlled trial
Background and objectives: Constipation is one of the most common gastrointestinal conditions, particularly among older individuals. This study aimed to evaluate the efficacy and safety of selected multistrain probiotics on functional constipation and laboratory blood parameters in the elderly living in a nursing home. Subjects and methods: Sixty participants (42 females and 18 males) aged 77.9 ± 8.84 years with functional constipation, who met the eligibility criteria, completed the study. In a double-blind, placebo-controlled, parallel design, each participant was randomized to receive either the selected probiotic mixture (N = 28) or placebo (N = 32) for 12 weeks as an adjunct to their usual diet and medications. The liquid probiotic formulation containing Bifidobacterium animalis subsp. lactis BLC1, Lactobacillus acidophilus LA3 and Lactobacillus casei BGP93 was tested for the first time. Results: Supplementation of selected probiotics resulted in a slight but nonsignificant increase in cumulative stool frequency compared with placebo. However, after the 71st day of the treatment, the cumulative number of stools was significantly higher in the probiotic group (P < 0.05) when the influence of laxative was excluded. The trend towards an increase in the difference between the two groups, which began 1 week after the probiotic intervention, pointed out to their prolonged effect. There were no significant dependent or independent effects of treatment and time on most of the 27 laboratory blood parameters tested. Conclusions: Multistrain probiotic supplementation was found to be efficacious, safe and well tolerated in the elderly with functional constipation.
- 4 August 2022
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 76 (12) , 1675-1681
Open AccessThe effect of multistrain probiotics on functional constipation in the elderly: a randomized controlled trial
Background and objectives: Constipation is one of the most common gastrointestinal conditions, particularly among older individuals. This study aimed to evaluate the efficacy and safety of selected multistrain probiotics on functional constipation and laboratory blood parameters in the elderly living in a nursing home. Subjects and methods: Sixty participants (42 females and 18 males) aged 77.9 ± 8.84 years with functional constipation, who met the eligibility criteria, completed the study. In a double-blind, placebo-controlled, parallel design, each participant was randomized to receive either the selected probiotic mixture (N = 28) or placebo (N = 32) for 12 weeks as an adjunct to their usual diet and medications. The liquid probiotic formulation containing Bifidobacterium animalis subsp. lactis BLC1, Lactobacillus acidophilus LA3 and Lactobacillus casei BGP93 was tested for the first time. Results: Supplementation of selected probiotics resulted in a slight but nonsignificant increase in cumulative stool frequency compared with placebo. However, after the 71st day of the treatment, the cumulative number of stools was significantly higher in the probiotic group (P < 0.05) when the influence of laxative was excluded. The trend towards an increase in the difference between the two groups, which began 1 week after the probiotic intervention, pointed out to their prolonged effect. There were no significant dependent or independent effects of treatment and time on most of the 27 laboratory blood parameters tested. Conclusions: Multistrain probiotic supplementation was found to be efficacious, safe and well tolerated in the elderly with functional constipation.
- Open Access
- 10 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (6) , 3276
Falsified Medicines Directive in a Secondary Care Environment—Impact on Supply Chain
The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive. This paper analyzes the supply chain of a hospital pharmacy and the impact of the FMD implementation. Furthermore, a cost analysis was performed demonstrating that the FMD increases expenditure in the secondary care environment dispensing operations. Governments should be aware that this regulation will certainly impact public healthcare institutions in the long term.
- 10 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (6) , 3276
Open AccessFalsified Medicines Directive in a Secondary Care Environment—Impact on Supply Chain
The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive. This paper analyzes the supply chain of a hospital pharmacy and the impact of the FMD implementation. Furthermore, a cost analysis was performed demonstrating that the FMD increases expenditure in the secondary care environment dispensing operations. Governments should be aware that this regulation will certainly impact public healthcare institutions in the long term.
- Open Access
- 22 February 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (5) , 2538
Patient Perceptions on Receiving Vaccination Services through Community Pharmacies
(1) Introduction: Pharmacists are medical professionals who play an active role in the protection of public health. Since 2021, pharmacists with an appropriate certification have been authorised to administer vaccines against COVID-19. (2) Objective: The objective of this study was to ascertain the perceptions of patients about receiving vaccinations through community pharmacies. (3) Material and methods: This study was conducted in 2021. The research tool was an anonymous questionnaire published on the websites of patient organisations. Ultimately, 1062 patients participated in this study. (4) Results: This study shows that most of the respondents find community pharmacies more accessible than outpatient clinics (85.3%). Sixty-one percent of the respondents stated that getting vaccinated at pharmacies would be less time consuming than at outpatient clinics. Nearly every third respondent (29.5%) declared that they would get vaccinated if they received such a recommendation from a pharmacist. Fifty-six percent of the respondents were of the opinion that the administration of vaccines by pharmacists would relieve the burden on medical staff and the healthcare system. (5) Conclusions: Polish patients participating in the study have a positive attitude towards the implementation of vaccination services in community pharmacies as an effective way of combating infectious diseases.
- 22 February 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (5) , 2538
Open AccessPatient Perceptions on Receiving Vaccination Services through Community Pharmacies
(1) Introduction: Pharmacists are medical professionals who play an active role in the protection of public health. Since 2021, pharmacists with an appropriate certification have been authorised to administer vaccines against COVID-19. (2) Objective: The objective of this study was to ascertain the perceptions of patients about receiving vaccinations through community pharmacies. (3) Material and methods: This study was conducted in 2021. The research tool was an anonymous questionnaire published on the websites of patient organisations. Ultimately, 1062 patients participated in this study. (4) Results: This study shows that most of the respondents find community pharmacies more accessible than outpatient clinics (85.3%). Sixty-one percent of the respondents stated that getting vaccinated at pharmacies would be less time consuming than at outpatient clinics. Nearly every third respondent (29.5%) declared that they would get vaccinated if they received such a recommendation from a pharmacist. Fifty-six percent of the respondents were of the opinion that the administration of vaccines by pharmacists would relieve the burden on medical staff and the healthcare system. (5) Conclusions: Polish patients participating in the study have a positive attitude towards the implementation of vaccination services in community pharmacies as an effective way of combating infectious diseases.
- Top Cited PapersOpen Access
- 1 January 2021
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (1) , 1807-1812
The legal extension of the role of pharmacists in light of the COVID-19 global pandemic
- 1 January 2021
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (1) , 1807-1812
Top Cited PapersOpen AccessThe legal extension of the role of pharmacists in light of the COVID-19 global pandemic